Skip to content

Scientific Monitoring of the Introduction of Respiratory Syncytial Virus (RSV) Immunisation in Germany: Acceptance, Implementation and Effectiveness – Qualitative Study in Module 1

Scientific Monitoring of the Introduction of Respiratory Syncytial Virus (RSV) Immunisation in Germany: Acceptance, Implementation and Effectiveness – Qualitative Study in Module 1

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040720
Enrollment
24
Registered
2026-06-22
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implementation of RSV immunisation by healthcare professionals

Interventions

Group 1: We will conduct individual qualitative expert interviews with healthcare professionals in Germany. The target population comprises healthcare professionals from three care settings: antenatal

Sponsors

Robert Koch-Institut
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Consent to study participation Eligibility for the target group

Exclusion criteria

Exclusion criteria: A person will be excluded from the study if the above-mentioned criteria are not met.

Design outcomes

Primary

MeasureTime frame
This qualitative study examines the components of the COM-B framework (Michie et al., 2011) in relation to vaccination communication and administration of the RSV immunisation by healthcare professionals. These components include Behaviour (e.g., how healthcare professionals conduct vaccination counselling), Capability (e.g., how confident they feel in doing so), Physical Opportunity (e.g., whether they perceive competing tasks, time pressure, or stress), Social Opportunity (e.g., how collaboration is organised and what norms are perceived in the work environment), and Motivation (e.g., attitudes towards childhood vaccinations and RSV immunisation).

Countries

Germany

Contacts

Public ContactElisa Wulkotte

Robert Koch-Institut

wulkottee@rki.de+4930 18754 3072

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026